IMMUNODEFICIENCY THERAPEUTICS MARKET ANALYSIS

Immunodeficiency Therapeutics Market, by Therapy Type (Immunoglobulin Therapy, Antibiotics Therapy, Stem Cell and Gene Therapy, and Others), by Test Type (Blood Test and Prenatal Testing), by Disease Type (Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In : Jul 2021
Code : CMI4543
Pages :163
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Restraints & Challenges:

High cost of immunodeficiency treatment
Side-effects of immunotherapy

Global Immunodeficiency Therapeutics Market – Restraints

However, growth of the immunodeficiency therapeutics market may be hampered, owing to high cost of immunotherapy and side effects of immunodeficiency disease treatment. For instance, according to an article published by ScienceDirect in April 2020, the total cost of immunodeficiency disease treatment is estimated to be US$ 6,500 to US$ 108,463 per patient.